The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations

The Impact of Chronic Liver Diseases on the Level of Heart-Type Fatty Acid-Binding Protein (H-FABP) Concentrations

Objectives: Heart-type fatty acid binding-protein (H-FABP) has been reported to be a potential novel biochemical marker for the early diagnosis of acute myocardial infarction (AMI). The presence of H-FABP in the liver has not been reported. The aim of this study was to compare the effect of chronic...

Full description

Bibliographic Details
Main Authors:	Hafidh A Al-Hadi, Brent William, Keith A Fox
Format:	Article
Language:	English
Published:	Sultan Qaboos University 2009-08-01
Series:	Sultan Qaboos University Medical Journal
Subjects:	heart-type fatty acid-binding protein (h-fabp) chronic liver diseases bilirubin alanine aminotransferase.
Online Access:	https://journals.squ.edu.om/index.php/squmj/article/view/1421

Similar Items

Altered Liver Function and the Status of Calcium in Postmenopausal Women in and Around Mangalore
by: Suchetha Kumari N, et al.
Published: (2010-04-01)

Parameters of liver function in patients with psoriasis vulgaris
by: Magdalena Oszukowska, et al.
Published: (2017-11-01)

Tracing the evolution of fatty acid‐binding proteins (FABPs) in organisms with a heterogeneous fat distribution
by: Yuru Zhang, et al.
Published: (2020-05-01)

Evaluation of Liver Enzymes in Normal Pregnancies in a University Hospital of Zabol Iran: A Cross-Sectional Study
by: Iraj Shahramian, et al.
Published: (2023-09-01)

The effect of magnesium supplementation and weight loss on liver enzymes in patients with nonalcoholic fatty liver disease
by: Majid Karandish, et al.
Published: (2013-01-01)

Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid membranes by different mechanisms
by: Alfred E.A. Thumser, et al.
Published: (2000-04-01)

Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease
by: Kyoung Ah Kwon, et al.
Published: (2016-09-01)

The role of fatty acid-binding proteins in evaluating kidney involvement in patients with ankylosing spondylitis
by: L. V. Plenkina, et al.
Published: (2020-02-01)

A Personal Retrospective: Elevating Anandamide (AEA) by Targeting Fatty Acid Amide Hydrolase (FAAH) and the Fatty Acid Binding Proteins (FABPs)
by: Dale Deutsch
Published: (2016-10-01)

Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments
by: Giuseppe Floresta, et al.
Published: (2022-11-01)

Toxicity of Margarine on Liver Enzymes (Aspartate Amino Transferas and Alanine Amino Transferase) in Rats
by: Zahra Salemi, et al.
Published: (2012-08-01)

Use of remaxol in the combination therapy of post-withdrawal disorders in alcoholic patients with comorbid liver damage
by: N A Bokhan, et al.
Published: (2012-10-01)

Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling
by: Mariah Farrell, et al.
Published: (2023-03-01)

Nonalcoholic fatty liver disease is a risk factor for glucose intolerance onset in men regardless of alanine aminotransferase status
by: Teruki Miyake, et al.
Published: (2021-10-01)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01)

Effect of Nutmeg on Transaminase Activities in Liver and Serum of Adult Wistar rats
by: P. E. Awhin, et al.
Published: (2023-03-01)

Prevalence and risk factors of elevated alanine aminotransferase among Korean adolescents: 2001-2014
by: Ju Whi Kim, et al.
Published: (2018-05-01)

Identification of the SNP (Single Nucleotide Polymorphism) for Fatty Acid Composition Associated with Beef Flavor-related FABP4 (Fatty Acid Binding Protein 4) in Korean Cattle
by: Dong-yep Oh, et al.
Published: (2012-07-01)

Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2<i>H</i>)-one as Novel Scaffold for FABP4 Inhibition
by: Letizia Crocetti, et al.
Published: (2022-10-01)

Eating quickly is associated with a low aspartate aminotransferase to alanine aminotransferase ratio in middle-aged adults: a large-scale cross-sectional survey in Japan
by: Eri Ozaki, et al.
Published: (2020-10-01)

Down-regulation of A-FABP predicts non-muscle invasive bladder cancer progression: investigation with a long term clinical follow-up
by: Christel Mathis, et al.
Published: (2018-12-01)

High expression of FABP4 and FABP6 in patients with colorectal cancer
by: Yaqin Zhang, et al.
Published: (2019-10-01)

Association between physical activity and serum liver aminotransferases in Southwestern Iran: A Cross-sectional study
by: Sajad Badiei, et al.
Published: (2022-01-01)

Effects of Ashwagandha (Withania somnifera) Root Extract On Some Serum Liver Marker Enzymes (AST, ALT) In Gentamicin Intoxicated Rats
by: Nayma Sultana, et al.
Published: (2012-06-01)

Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study
by: Hirotaka Ochiai, et al.
Published: (2020-11-01)

Therapeutic Effects of Green Tea on Nonalcoholic Fatty Liver Disease in 10-16-Year-Old Children
by: Noushin Rostampour, et al.
Published: (2019-07-01)

ТiО(2) hepatotoxicity under long-term administration to rats
by: O. V. Tsymbalyuk, et al.
Published: (2020-08-01)

Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors
by: Rosario Tomarchio, et al.
Published: (2023-03-01)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
by: Julia Nowowiejska, et al.
Published: (2022-04-01)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
by: Takako Mukai, et al.
Published: (2017-07-01)

The significance of hepatic transaminases and ultrasound in the diagnosis of non-alcoholic fatty liver disease
by: Y. M. Stepanov, et al.
Published: (2018-03-01)

Assessment of Propolis Supplementation on Serum Concentrations of Liver Enzymes in Endurance Athletes with Four Weeks Aerobic Training
by: Mojtaba Mahdavi Asiabar, et al.
Published: (2021-04-01)

The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
by: Ben Li, et al.
Published: (2022-09-01)

Clinical significance of urinary L-FABP in the emergency department
by: Ginga Suzuki, et al.
Published: (2019-08-01)

Tumor-Targeting Peptides: The Functional Screen of Glioblastoma Homing Peptides to the Target Protein FABP3 (MDGI)
by: Abiodun Ayo, et al.
Published: (2020-07-01)

Genetic variants associated with circulating liver injury markers in Mexican Americans, a population at risk for non-alcoholic fatty liver disease
by: Caroline M. Sabotta, et al.
Published: (2022-10-01)

Investigation of the Effect of Creatine Monohydrate Supplementation on Mmuscle Damage in Male Climbers following Climbing to an Altitude of 4000 Meter
by: Javad Ziaolhagh, et al.
Published: (2020-07-01)

Serum Level of Heart-Type Fatty Acid-Binding Protein in Patients with Chronic Renal Failure
by: Hafidh A Al-Hadi, et al.
Published: (2009-12-01)

The effects of low carbohydrate diets on liver function tests in nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials
by: Fahimeh Haghighatdoost, et al.
Published: (2016-01-01)

FABP5 Inhibition against <i>PTEN</i>-Mutant Therapy Resistant Prostate Cancer
by: Manojit M. Swamynathan, et al.
Published: (2023-12-01)